Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Keating

Showing results (141-150 of 1,288) with videos related to

Pageof 129
Sort By:
Leukemia & Lymphoma|February 16, 2000
Chronic lymphoproliferative disorders: an integrated point of view for the differential diagnosisG D'Arena, M J Keating, M Carotenuto
Expert Opinion on Biological Therapy|December 1, 2001
Alemtuzumab: a novel monoclonal antibodyA Ferrajoli, S O'Brien, M J Keating
The Journal of Pedodontics|January 1, 1985
Traumatic impaction of a maxillary primary incisor into the nasal cavityM Rakocz, J Keating, T P Croll
Cancer Treatment Reports|May 1, 1987
Effect of amsacrine on ara-CTP cellular pharmacology in human leukemia cells during high-dose cytarabine therapyW Plunkett, B Nowak, M J Keating
ACS Applied Materials & Interfaces|October 7, 2016
Polymer Brushes for Membrane Separations: A ReviewJohn J Keating, Joseph Imbrogno, Georges Belfort
Injury|February 21, 2006
Grading the evidence: levels of evidence and grades of recommendationB A Petrisor, J Keating, E Schemitsch
Seminars in Oncology|February 14, 2002
Emerging information on the use of rituximab in chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar
European Journal of Cancer Care|February 14, 1998
Low-grade non-Hodgkin's lymphoma--development of a new effective combination regimen (fludarabine, mitoxantrone and dexamethasone; FND)M J Keating, P McLaughlin, F Cabanillas
Current Hematologic Malignancy Reports|April 29, 2010
New aspects of the treatment of chronic lymphocytic leukemiaStefan Faderl, William Wierda, Michael J Keating
Best Practice & Research. Clinical Haematology|September 26, 2006
Monoclonal antibody combinations in CLL: evolving strategiesStefan Faderl, Susan O'Brien, Michael J Keating
Pageof 129

Showing results (141-150 of 1,288) with videos related to

Sort By:
Pageof 129
Leukemia & Lymphoma|February 16, 2000
Chronic lymphoproliferative disorders: an integrated point of view for the differential diagnosisG D'Arena, M J Keating, M Carotenuto
Expert Opinion on Biological Therapy|December 1, 2001
Alemtuzumab: a novel monoclonal antibodyA Ferrajoli, S O'Brien, M J Keating
The Journal of Pedodontics|January 1, 1985
Traumatic impaction of a maxillary primary incisor into the nasal cavityM Rakocz, J Keating, T P Croll
Cancer Treatment Reports|May 1, 1987
Effect of amsacrine on ara-CTP cellular pharmacology in human leukemia cells during high-dose cytarabine therapyW Plunkett, B Nowak, M J Keating
ACS Applied Materials & Interfaces|October 7, 2016
Polymer Brushes for Membrane Separations: A ReviewJohn J Keating, Joseph Imbrogno, Georges Belfort
Injury|February 21, 2006
Grading the evidence: levels of evidence and grades of recommendationB A Petrisor, J Keating, E Schemitsch
Seminars in Oncology|February 14, 2002
Emerging information on the use of rituximab in chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar
European Journal of Cancer Care|February 14, 1998
Low-grade non-Hodgkin's lymphoma--development of a new effective combination regimen (fludarabine, mitoxantrone and dexamethasone; FND)M J Keating, P McLaughlin, F Cabanillas
Current Hematologic Malignancy Reports|April 29, 2010
New aspects of the treatment of chronic lymphocytic leukemiaStefan Faderl, William Wierda, Michael J Keating
Best Practice & Research. Clinical Haematology|September 26, 2006
Monoclonal antibody combinations in CLL: evolving strategiesStefan Faderl, Susan O'Brien, Michael J Keating
Pageof 129